Following a limited submission
AWMSG advice |
|||
Status: Recommended | |||
Fosfomycin (Fomicyt®) is recommended as an option for use within NHS Wales for the treatment of the following infections in adults and children including neonates:
Fosfomycin (Fomicyt®) should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of the infections listed above, or when these alternative antibacterial agents have failed to demonstrate efficacy. |
|||
|
|||
Medicine details |
|||
Medicine name | fosfomycin (Fomicyt®) | ||
Formulation | 40 mg/ml powder for solution for infusion | ||
Reference number | 2710 | ||
Indication | Treatment of the following infections in adults and children including neonates:
|
||
Company | Nordic Pharma UK Ltd | ||
BNF chapter | Infections | ||
Submission type | Limited | ||
Status | Recommended | ||
Advice number | 2710 | ||
NMG meeting date | 09/09/2015 | ||
AWMSG meeting date | 21/10/2015 | ||
Ratification by Welsh Government | 17/11/2015 | ||
Date of issue | 18/11/2015 | ||
Date of last review | 02/04/2019 |